B-cell prolymphocytic leukemia other diagnostic studies

B-cell prolymphocytic leukemia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
B-cell prolymphocytic leukemia other diagnostic studies On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on B-cell prolymphocytic leukemia other diagnostic studies
CDC on B-cell prolymphocytic leukemia other diagnostic studies
B-cell prolymphocytic leukemia other diagnostic studies in the news
Blogs on B-cell prolymphocytic leukemia other diagnostic studies
Directions to Hospitals Treating B-cell prolymphocytic leukemia
Risk calculators and risk factors for B-cell prolymphocytic leukemia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]

Overview

Other diagnostic studies for acute lymphoblastic leukemia include immunophenotyping.

Immunophenotyping

The flow cytometric immunophenotyping indicates that the most common malignant cells are positive for:

• CD20
• CD22
• CD23
• CD79a
• CD79b
• FMC7
• Strong surface IgM +/- IgD